Eyetelligence Assure

Software system utilizing artificial intelligence algorithms to analyze retinal imaging data. Processes fundus photographs to identify pathological changes and generates clinical reports. Integrates with pharmacy and health center networks for distributed screening programs.

EyeKnow is an AI-powered eye-tracking system for cognitive and neurological assessment. It records and analyzes eye movement trajectories to evaluate brain health, cognitive function, and neurodegenerative conditions. The platform integrates advanced eye-tracking hardware with artificial intelligence for screening, diagnosis, and monitoring of neurological disorders across clinical settings.

AI-powered screening system for diabetic retinopathy detection using fundus imaging. Enables non-invasive, population-scale vision screening in primary care and community settings to identify patients requiring specialist referral. Combines portable fundus photography with machine learning algorithms for early disease detection and risk stratification.

A cloud-based, AI-powered platform that delivers hospital-grade visual field testing for glaucoma detection accessible via any computer or device without requiring specialized hardware. The system uses AI webcam monitoring for patient positioning and generates detailed visual field maps by comparing sensitivity at multiple test points against age-matched normal data. It eliminates traditional clinic machinery barriers, reducing costs while improving accessibility in underserved regions.

* WISKY: AI-Powered Retinal Disease Diagnostic Solution WISKY is an advanced solution that performs real-time analysis of images captured by fundus cameras to detect age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma. It serves as a vital tool for internal medicine clinics, family medicine practices, and health screening centers, assisting in the early detection, prevention, and management of the three leading causes of blindness.

An AI and telemedicine platform providing three integrated diagnostic capabilities for eye disease screening and monitoring. This platform enables automated analysis and remote review of retinal images for comprehensive eye health assessment.

AI-powered non-invasive health screening system that integrates multimodal optical imaging with computational biology models to assess multiple health parameters including glucose, blood pressure, and body composition from facial analysis. Combines digital biomarkers with machine learning algorithms for real-time multi-dimensional health predictions across clinical and consumer health settings.

Automated imaging analysis system utilizing artificial intelligence to convert medical imaging data into actionable clinical insights for improved diagnostic accuracy.

AI-based diagnostic support tools for image analysis and clinical decision support. These solutions enhance diagnostic accuracy and workflow efficiency.

Artificial intelligence software for automated image interpretation and clinical decision support. Processes medical imaging data to provide actionable diagnostic insights.

An AI-powered intelligent imaging diagnostic solution that provides computer-assisted analysis of medical images. Supports enhanced diagnostic accuracy and clinical decision-making.

Aireen’s core product is a fully autonomous diagnostic platform that uses a cascade of neural networks to analyse retina images and identify markers of chronic diseases, delivering results within seconds. The technology is trained on over a million annotated fundus images to ensure high-quality, reliable screening while guarding against operator error, such as poor image quality, and is camera-agnostic to integrate with a wide range of fundus imaging devices. The platform currently supports detection of diabetic retinopathy and age related macular degeneration, with ongoing development aimed at extending capabilities to cardiovascular and neurodegenerative disease screening. Aireen is offered as a cloud-based service with a pay-as-you-go model, helping healthcare providers save time and costs while enabling early detection and intervention. The company has one trademark.